Sorry, you need to enable JavaScript to visit this website.

Skip to main content


Washington University Research Alliance

Research Alliance Marks Innovative Collaboration in Type 1 Diabetes

Disease Interception Accelerator

Disease Interception Accelerator

The Disease Interception Accelerator and Janssen Pharmaceuticals, Inc. entered into a research agreement with Washington University and award-winning immunologist Emil Unanue, M.D., Paul & Ellen Lacy Professor of Pathology & Immunology at Washington University, to identify the root cause of type 1 diabetes and enable the development of interventions that halt progression to disease.